Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

During the Trading Day
44.06 -0.34 / -0.77%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
44.06 0.00 / 0.00%
 
Volume: 21.7K

Today’s Trading

Previous close44.40
Today’s open44.63
Day’s range43.00 - 44.65
Volume468,084
Average volume (3 months)944,291
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)-26.06%
Earnings growth (this year)-4.77%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+123.72%
P/E ratio84.6
Price/Sales6.96
Price/Book18.95

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-1.20-1.38%
CBPOChina Biologic Produ...+2.24+1.88%
WXWuXi PharmaTech (Cay...+0.70+1.72%
IPXLImpax Laboratories I...-0.83-1.69%
Data as of 4:02pm ET, 07/29/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.23
Annual revenue (last year)$222.1M
Annual profit (last year)$38.0M
Net profit margin17.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael L. Babich
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts